151 related articles for article (PubMed ID: 29226622)
1. PDE4 inhibitor rolipram inhibits the expression of microsomal prostaglandin E synthase-1 by a mechanism dependent on MAP kinase phosphatase-1.
Tuure L; Hämäläinen M; Moilanen E
Pharmacol Res Perspect; 2017 Dec; 5(6):. PubMed ID: 29226622
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of microsomal prostaglandin E synthase-1 (mPGES-1) expression in chondrocytes is regulated by MAP kinase phosphatase-1 (MKP-1).
Tuure L; Hämäläinen M; Nummenmaa E; Moilanen T; Moilanen E
Int Immunopharmacol; 2019 Jun; 71():139-143. PubMed ID: 30897501
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of TNF production and experimentally induced inflammation by PDE4 inhibitor rolipram is mediated by MAPK phosphatase-1.
Korhonen R; Hömmö T; Keränen T; Laavola M; Hämäläinen M; Vuolteenaho K; Lehtimäki L; Kankaanranta H; Moilanen E
Br J Pharmacol; 2013 Aug; 169(7):1525-36. PubMed ID: 23849041
[TBL] [Abstract][Full Text] [Related]
4. Microsomal Prostaglandin E Synthase-1 Expression in Inflammatory Conditions Is Downregulated by Dexamethasone: Seminal Role of the Regulatory Phosphatase MKP-1.
Tuure L; Hämäläinen M; Whittle BJ; Moilanen E
Front Pharmacol; 2017; 8():646. PubMed ID: 28983247
[TBL] [Abstract][Full Text] [Related]
5. MKP-1 negative regulates Staphylococcus aureus induced inflammatory responses in Raw264.7 cells: roles of PKA-MKP-1 pathway and enhanced by rolipram.
Pan Y; Xu C; Pan ZK
Sci Rep; 2017 Sep; 7(1):12366. PubMed ID: 28959039
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of microsomal prostaglandin E synthase-1 facilitates liver repair after hepatic injury in mice.
Nishizawa N; Ito Y; Eshima K; Ohkubo H; Kojo K; Inoue T; Raouf J; Jakobsson PJ; Uematsu S; Akira S; Narumiya S; Watanabe M; Majima M
J Hepatol; 2018 Jul; 69(1):110-120. PubMed ID: 29458169
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of Phosphodiesterase 4, but Not Phosphodiesterase 3, Increase β2-Agonist-Induced Expression of Antiinflammatory Mitogen-Activated Protein Kinase Phosphatase 1 in Airway Smooth Muscle Cells.
Patel BS; Prabhala P; Oliver BG; Ammit AJ
Am J Respir Cell Mol Biol; 2015 May; 52(5):634-40. PubMed ID: 25296132
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of GSK-3 reduces prostaglandin E2 production by decreasing the expression levels of COX-2 and mPGES-1 in monocyte/macrophage lineage cells.
Noma T; Takahashi-Yanaga F; Arioka M; Mori Y; Sasaguri T
Biochem Pharmacol; 2016 Sep; 116():120-9. PubMed ID: 27453433
[TBL] [Abstract][Full Text] [Related]
9. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
[TBL] [Abstract][Full Text] [Related]
10. Poly(I:C) increases the expression of mPGES-1 and COX-2 in rat primary microglia.
de Oliveira AC; Yousif NM; Bhatia HS; Hermanek J; Huell M; Fiebich BL
J Neuroinflammation; 2016 Jan; 13():11. PubMed ID: 26780827
[TBL] [Abstract][Full Text] [Related]
11. Signal pathways involved in the regulation of prostaglandin E synthase-1 in human gingival fibroblasts.
Yucel-Lindberg T; Olsson T; Kawakami T
Cell Signal; 2006 Dec; 18(12):2131-42. PubMed ID: 16766159
[TBL] [Abstract][Full Text] [Related]
12. Powerful relaxation of phosphodiesterase type 4 inhibitor rolipram in the pig and human bladder neck.
Ribeiro ASF; Fernandes VS; Martínez-Sáenz A; Martínez P; Barahona MV; Orensanz LM; Blaha I; Serrano-Margüello D; Bustamante S; Carballido J; García-Sacristán A; Prieto D; Hernández M
J Sex Med; 2014 Apr; 11(4):930-941. PubMed ID: 24754330
[TBL] [Abstract][Full Text] [Related]
13. MKP-1 negatively regulates LPS-mediated IL-1β production through p38 activation and HIF-1α expression.
Talwar H; Bauerfeld C; Bouhamdan M; Farshi P; Liu Y; Samavati L
Cell Signal; 2017 Jun; 34():1-10. PubMed ID: 28238855
[TBL] [Abstract][Full Text] [Related]
14. Shunting of prostanoid biosynthesis in microsomal prostaglandin E synthase-1 null embryo fibroblasts: regulatory effects on inducible nitric oxide synthase expression and nitrite synthesis.
Kapoor M; Kojima F; Qian M; Yang L; Crofford LJ
FASEB J; 2006 Nov; 20(13):2387-9. PubMed ID: 17023389
[TBL] [Abstract][Full Text] [Related]
15. Anti-Inflammatory Effects of β2-Receptor Agonists Salbutamol and Terbutaline Are Mediated by MKP-1.
Keränen T; Hömmö T; Hämäläinen M; Moilanen E; Korhonen R
PLoS One; 2016; 11(2):e0148144. PubMed ID: 26849227
[TBL] [Abstract][Full Text] [Related]
16. Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs.
Nieminen R; Korhonen R; Moilanen T; Clark AR; Moilanen E
Arthritis Rheum; 2010 Jun; 62(6):1650-9. PubMed ID: 20178133
[TBL] [Abstract][Full Text] [Related]
17. Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages.
Chen P; Li J; Barnes J; Kokkonen GC; Lee JC; Liu Y
J Immunol; 2002 Dec; 169(11):6408-16. PubMed ID: 12444149
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of mPGES-1 inhibitors to macrophages via the folate receptor-β for inflammatory pain.
Mazaleuskaya LL; Lee S; Meng H; Winkler JD; FitzGerald GA
Bioorg Med Chem Lett; 2021 Oct; 50():128313. PubMed ID: 34390827
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of microsomal prostaglandin E-synthase-1 (mPGES-1) selectively suppresses PGE
Martin EM; Jones SL
Vet Immunol Immunopathol; 2017 Oct; 192():33-40. PubMed ID: 29042013
[TBL] [Abstract][Full Text] [Related]
20. Augmented liver inflammation in a microsomal prostaglandin E synthase 1 (mPGES-1)-deficient diet-induced mouse NASH model.
Henkel J; Coleman CD; Schraplau A; Jöhrens K; Weiss TS; Jonas W; Schürmann A; Püschel GP
Sci Rep; 2018 Oct; 8(1):16127. PubMed ID: 30382148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
